Advertisement

Topics

Latest "Demegen Incorporated" News Stories

12:47 EST 19th February 2018 | BioPortfolio

Here are the most relevant search results for "Demegen Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Demegen Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Demegen Incorporated for you to read. Along with our medical data and news we also list Demegen Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Demegen Incorporated Companies for you to search.

Showing "Demegen Incorporated" News Articles 1–25 of 38

Thursday 15th February 2018

Relevium Announces 2018 AGM Results

MONTREAL, QUEBEC -- (Marketwired) -- 02/16/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montreal, Canada (the "AGM"). Election of Directors The shareholders supported the appointment of the Board and the resolutions prop...


Monday 12th February 2018

Horizon Discovery enters into license agreement with US immuno-oncology company.

Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies, demonstrating Horizon’s ability to generate revenues from internally derived IP Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturin...

Monday 5th February 2018

Intellegens secures first commercial contract for Alchemite™ technology

Cambridge, UK - 5 February 2018 - The potential of Intellegens’ Alchemite™ artificial intelligence (AI) technology has been demonstrated with the recent announcement of a commercial collaboration between the Cambridge-based company and e-Therapeutics; the Oxford-based pioneer of Network-Driven Drug Discovery (NDD). In its first commercial application, Alchemite™ will enable ...


Sunday 4th February 2018

Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement

MONTREAL, QUEBEC -- (Marketwired) -- 02/05/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate secretary on a share for services agreement. Improved Financial Position and Warrants Exercises to-date The c...

Tuesday 30th January 2018

Global Carbon refractories Market Research Report Forecast 2017 to 2021 [Report Updated: 20112017] Prices from USD $2800

The Global Carbon refractories Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Carbon refractories industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its distributor analysis. Thi...

Monday 22nd January 2018

Avacta and Oncosec to Collaborate on Innovative Gene Delivery of Therapeutic Affimers

Wetherby and Cambridge, UK, 22 January 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, are pleased to announce they have entered into a research collaboration to combine Avacta’s Affimer protein platform with Onc...

Wednesday 17th January 2018

Relevium to Host Webcast to Discuss Previously Announced Blockchain Project

MONTREAL, QUEBEC -- (Marketwired) -- 01/18/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTC PINK: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent e-retail platform and artificial intelligence technology stack. Management and the Board of Relevium ha...

Tuesday 16th January 2018

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 16, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") announced today that it received transparency notifications pursuant to Article 14 of the Belgian Law of May 2, 2007 regarding the publication of maj...

Monday 15th January 2018

MedPharm launches new automated performance testing services, MedStat-HTTM and MedFlux-HT® for de-risking and accelerating the development of topical medicines

MedPharm, the world leader in formulation and in vitro performance testing of topical medicines, has launched two automated testing services, MedStat-HT and MedFlux-HT® to de-risk client’s development programs and shorten development timelines. Both pieces of equipment incorporated design features which provide significant improvements over commercially available systems. MedFlux-HT...

Wednesday 10th January 2018

Relevium Signs JV for E-Commerce AI With Blockchain Technology Integration, Proposes Initial Coin Offering

MONTREAL, QUEBEC -- (Marketwired) -- 01/11/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the signing of a joint venture agreement ("JV") with Quantomic LLC (the "Parties") for Tagspire, a virtual retail and visual commerce platform. Highlights Note to reader: There are multiple hyperlinks in this news release. If the re...

Tuesday 2nd January 2018

Teleflex Completes Previously Announced CEO Transition

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announced today that it has completed its previously announced senior leadership transition. Effective January 1, 2018, Liam Kelly, who previously served as Teleflex’s President and Chief Operating Officer, assumed the position of Presiden...

Wednesday 27th December 2017

NOTICE IN RELATION TO WAIVER OF LOCK-UP RESTRICTION

REGULATED INFORMATION GHENT, Belgium, 27 December 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Jefferies LLC, the lead book-running managers in the Company's recent public sale of 13,144,500 ordinary shares in the form of American Depositary Shares, including 1,714...

Thursday 14th December 2017

FIT Biotech Oy: Resolutions of Extraordinary General Meeting December 14, 2017

FIT Biotech OyCompany release December 14, 2017 at 12 am. Resolutions of Extraordinary General Meeting December 14, 2017                The EGM of FIT Biotech ("FIT Biotech", "company") has made the following resolutions today. Amendment to the Articles of Association    The Extraordinary General Meeting resolved to amend section 4 of ...

Thursday 7th December 2017

Novartis tender offer for Advanced Accelerator Applications commences

Novartis International AG / Novartis tender offer for Advanced Accelerator Applications commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, December 7, 2017 -Novartis AG (NYSE: NVS) ("Novartis") today announced that its direct and indirect subsidiary, Novartis Groupe France S...

Monday 4th December 2017

Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink

CALGARY, Alberta, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has closed its previously announced private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. ("Hepalink") at a price of $1.44 per unit for gross proceeds of $87 million. Each unit was comprised ...

Friday 1st December 2017

Copley Scientific to showcase new TPK™ 2100 Critical Flow Controller for dry powder inhaler testing at DDL2017

A highly automated system to speed up testing, improve reproducibility, and enhance data output and recording Monday 27th November: Nottingham, UK: Copley Scientific, the world’s leading manufacturer of inhaler test equipment, will be presenting its new 3rd generation Critical Flow Controller – the TPK™ 2100 – for the testing of dry powder inhalers (DPIs) at the 2017 Dr...

Copley Scientific introduces new, upgraded breath simulators for inhaled product testing.

13th November 2017: Nottingham, UK: Copley Scientific, the world’s leading manufacturer of inhaler test equipment, launches new advanced breath simulators, the BRS 2100 and BRS 3100, for orally inhaled product (OIP) development and testing. In recent years, in response to regulatory and pharmacopoeial changes, and the drive to ensure closer correlation between in vivo and in vitro performa...

Thursday 30th November 2017

U.S. FDA Grants Shire Orphan Drug Designation for Investigational Anti-MAdCAM Antibody SHP647 for the Treatment of Moderately to Severely Active Ulcerative Colitis in Pediatric Patients

U.S. FDA Grants Shire Orphan Drug Designation for Investigational Anti-MAdCAM Antibody SHP647 for the Treatment of Moderately to Severely Active Ulcerative Colitis in Pediatric Patients Cambridge, Ma.  - November 30, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the world's leading biotechnology company in rare diseases, today announced that the U.S. Food and Drug Administra...

Monday 27th November 2017

Milestone Scientific's CompuFlo(R) Epidural System, Wand(R) STA Dental System and Cosmetic Instrument Featured in Television Broadcasts and in Premier Online News Journal

LIVINGSTON, NJ--(Marketwired - November 28, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Wand® STA Dental and CompuFlo® Epidural systems were featured in separate television news broadcasts in Pittsburgh and South Florida, respectively....

Thursday 16th November 2017

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on November 20, 2017, subject to customary closing conditions. The Notes will be guar...

Teleflex Incorporated Announces Public Offering of $500 Million of Senior Notes

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the registered public offering, subject to market and other conditions, of $500.0 million aggregate principal amount of senior notes due 2027 (the “Notes”). The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Tel...

Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction

Molecular Health GmbH / Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Cambridge, MA, USA - November 16, 2017 -  Molecular Health, Inc (MH), a company marketing computational biomedicine...

Friday 10th November 2017

Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and Oncology

Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and Oncology Lexington, Mass. - November 10, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving people with rare diseases, today announced the broad range of research it will present at the 59th American Society of Hematology (ASH) A...

Thursday 9th November 2017

Ligand Reports Third Quarter 2017 Financial Results

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2017, and provided an operating forecast and program updates. “Ligand’s diversified business is performing well on all levels. In the third quarter, we posted strong financial results driven by royalties and sig...

Wednesday 8th November 2017

Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults

BERKELEY, CA--(Marketwired - November 09, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in t...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks